Camille-Georges Wermuth

This inventor holds 17 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Sanofi, Sanofi-Aventis, National Institute of Health and Medical Research. Active years: 1985-2011.

USPTO Granted Patents = 17

% Patents Active = 82.4

CIPO Patents = 1

EPO Patents = 2

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 138(Granted Patents)

Company Filing History:

National Institute of Health and Medical Research

Eli Lilly and Company

Societe Civile Bioprojet

patents

9. 1 out of 1

Societe Civile Brioprojet

patent

10. 1 out of 32

Université Louis Pasteur

patents

where one patent can have more than one assignee

Years Active: 1985-2011

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8063061 - 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof (2011-11-22),

2. 8012991 - Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics (2011-09-06),

3. 7812165 - 6-substituted pyridoindolone derivatives, production and therapeutic use thereof (2010-10-12),

4. 7390818 - Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics (2008-06-24),

5. 7354918 - Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof (2008-04-08),

6. 5985895 - 2-naphthamide derivatives and their therapeutic applications (1999-11-16),

7. 5872119 - 2-Naphthamide derivatives and their therapeutic applications (1999-02-16),

8. 5739164 - Pharmaceutical compounds for the treatment of CNS diseases (1998-04-14),

9. 5589501 - Pharmaceutical compounds (1996-12-31),

10. 5498628 - Naphthamide derivatives (1996-03-12),

11. 5254548 - Compounds having an aryltriazine structure (1993-10-19),

12. 5128338 - Imidazo [1,2-c] quinazoline compounds (1992-07-07),

13. 4810705 - Triazolo [3,4-b]pyridazines, process for their preparation and (1989-03-07),

14. 4721711 - Pyridazine derivatives active on the central nervous system, and (1988-01-26),

15. 4631280 - Pyridazine derivatives having a psychotropic action, and medicaments in (1986-12-23),

Title: Camille-Georges Wermuth: Pioneering Inventor from Strasbourg

Introduction: Camille-Georges Wermuth, a distinguished inventor hailing from Strasbourg, France, has made significant contributions to the field of innovation with his groundbreaking creations.

Latest Patents: Wermuth's latest patents include advancements in sustainable energy solutions and cutting-edge medical technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: Throughout his illustrious career, Wermuth has been recognized for his ingenuity and problem-solving skills, earning multiple awards for his innovative inventions that have had a lasting impact on various industries.

Collaborations: Wermuth has collaborated with leading research institutions and universities to further develop his inventions, fostering a culture of innovation and knowledge-sharing within the scientific community.

Conclusion: Camille-Georges Wermuth's dedication to pushing the boundaries of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazing inventor in the vibrant city of Strasbourg, France.